181 related articles for article (PubMed ID: 2509437)
1. Treatment of imipramine-resistant recurrent depression: II. An open clinical trial of lithium augmentation.
Thase ME; Kupfer DJ; Frank E; Jarrett DB
J Clin Psychiatry; 1989 Nov; 50(11):413-7. PubMed ID: 2509437
[TBL] [Abstract][Full Text] [Related]
2. Treatment of imipramine-resistant recurrent depression: I. An open clinical trial of adjunctive L-triiodothyronine.
Thase ME; Kupfer DJ; Jarrett DB
J Clin Psychiatry; 1989 Oct; 50(10):385-8. PubMed ID: 2676995
[TBL] [Abstract][Full Text] [Related]
3. The pharmacotherapy of depressive illness in adolescence: II. Effects of lithium augmentation in nonresponders to imipramine.
Strober M; Freeman R; Rigali J; Schmidt S; Diamond R
J Am Acad Child Adolesc Psychiatry; 1992 Jan; 31(1):16-20. PubMed ID: 1537769
[TBL] [Abstract][Full Text] [Related]
4. Treatment of imipramine-resistant recurrent depression, III: Efficacy of monoamine oxidase inhibitors.
Thase ME; Frank E; Mallinger AG; Hamer T; Kupfer DJ
J Clin Psychiatry; 1992 Jan; 53(1):5-11. PubMed ID: 1737741
[TBL] [Abstract][Full Text] [Related]
5. Adequate treatment with imipramine in continuation treatment.
Kupfer DJ; Perel JM; Frank E
J Clin Psychiatry; 1989 Jul; 50(7):250-5. PubMed ID: 2661546
[TBL] [Abstract][Full Text] [Related]
6. Adjunctive lithium carbonate in nortriptyline-resistant elderly depressed patients.
Zimmer B; Rosen J; Thornton JE; Perel JM; Reynolds CF
J Clin Psychopharmacol; 1991 Aug; 11(4):254-6. PubMed ID: 1918424
[TBL] [Abstract][Full Text] [Related]
7. Low dosage lithium augmentation in venlafaxine resistant depression: an open-label study.
Alevizos B; Alevizos E; Leonardou A; Zervas I
Psychiatriki; 2012; 23(2):143-8. PubMed ID: 22796912
[TBL] [Abstract][Full Text] [Related]
8. Adjunct low dose lithium carbonate in treatment-resistant depression: a placebo-controlled study.
Zusky PM; Biederman J; Rosenbaum JF; Manschreck TC; Gross CC; Weilberg JB; Gastfriend DR
J Clin Psychopharmacol; 1988 Apr; 8(2):120-4. PubMed ID: 3131389
[TBL] [Abstract][Full Text] [Related]
9. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
[TBL] [Abstract][Full Text] [Related]
10. Long-term treatment of depression.
Kupfer DJ
J Clin Psychiatry; 1991 May; 52 Suppl():28-34. PubMed ID: 1903134
[TBL] [Abstract][Full Text] [Related]
11. Interpersonal psychotherapy and antidepressant medication: evaluation of a sequential treatment strategy in women with recurrent major depression.
Frank E; Grochocinski VJ; Spanier CA; Buysse DJ; Cherry CR; Houck PR; Stapf DM; Kupfer DJ
J Clin Psychiatry; 2000 Jan; 61(1):51-7. PubMed ID: 10695647
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of the effectiveness of two treatment strategies in inpatients with a depressive disorder. A double-blind study of imipramine followed by lithium addition versus fluvoxamine followed by lithium addition].
Birkenhäger TK; van den Broek WW; Mulder PG; Bruijn JA; Moleman P
Tijdschr Psychiatr; 2006; 48(4):271-81. PubMed ID: 16955991
[TBL] [Abstract][Full Text] [Related]
13. [Lithium carbonate augmentation in tricyclic antidepressant-resistant depression].
Dorevitch A; Ginath Y
Harefuah; 1991 Dec; 121(11):429-30. PubMed ID: 1786889
[TBL] [Abstract][Full Text] [Related]
14. Quetiapine augmentation of treatment-resistant depression: a comparison with lithium.
Dorée JP; Des Rosiers J; Lew V; Gendron A; Elie R; Stip E; Tourjman SV
Curr Med Res Opin; 2007 Feb; 23(2):333-41. PubMed ID: 17288688
[TBL] [Abstract][Full Text] [Related]
15. Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms.
Bschor T; Lewitzka U; Sasse J; Adli M; Köberle U; Bauer M
Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S230-4. PubMed ID: 14677084
[TBL] [Abstract][Full Text] [Related]
16. Switching versus augmentation: a prospective, naturalistic comparison in depressed, treatment-resistant patients.
Posternak MA; Zimmerman M
J Clin Psychiatry; 2001 Feb; 62(2):135-42; quiz 143. PubMed ID: 11247104
[TBL] [Abstract][Full Text] [Related]
17. Lithium augmentation therapy in refractory depression-update 2002.
Bauer M; Forsthoff A; Baethge C; Adli M; Berghöfer A; Döpfmer S; Bschor T
Eur Arch Psychiatry Clin Neurosci; 2003 Jun; 253(3):132-9. PubMed ID: 12904977
[TBL] [Abstract][Full Text] [Related]
18. [Therapy refractory depression].
Hatzinger M; Holsboer-Trachsler E
Wien Med Wochenschr; 1999; 149(18):511-4. PubMed ID: 10637955
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacological treatment of delusional depression].
Amore M; Giordani L; Giorgetti G; Zazzeri N
Minerva Psichiatr; 1996 Mar; 37(1):29-33. PubMed ID: 8804200
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of lithium augmentation in antidepressant-resistant geriatric depression.
Flint AJ; Rifat SL
J Clin Psychopharmacol; 1994 Oct; 14(5):353-6. PubMed ID: 7806693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
